A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Astellas Pharma Inc
Astellas Pharma Inc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AbbVie
Iambic Therapeutics, Inc
Amgen
Conjupro Biotherapeutics, Inc.
Turning Point Therapeutics, Inc.
DeuterOncology
Alterome Therapeutics, Inc.
Tempus AI
Peking University People's Hospital
Pheon Therapeutics
Avera McKennan Hospital & University Health Center
Pfizer
Aptamer Sciences, Inc.
Eli Lilly and Company
Conjupro Biotherapeutics, Inc.
RasCal Therapeutics, Inc.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Eisai Inc.
AbbVie
Revolution Medicines, Inc.
UMC Utrecht
University of Aarhus
Nuvectis Pharma, Inc.
Palo Alto Veterans Institute for Research
ViroMissile, Inc.
Amgen
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
A2 Biotherapeutics Inc.
University of Florida
VA Office of Research and Development
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
National Institutes of Health Clinical Center (CC)
A2 Biotherapeutics Inc.
New Phase Ltd.
Revolution Medicines, Inc.
Tempus AI
Icahn School of Medicine at Mount Sinai
DualityBio Inc.
Grey Wolf Therapeutics
EXoPERT
Elephas
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals